IPO Date: Aug 26 to Aug 29 2025
Listing Date: Sep 3 2025
1. Funding capital expenditure requirements for expansion of our Manufacturing Facility (“Proposed Expansion”);
2. Full or part repayment and/or prepayment of certain outstanding secured borrowings (term loan) availed by our Company;
3. Funding the working capital requirements of our Company; and
4. General corporate purposes.
...
a Intermediate”) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients (“APIs”) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (“FDF”) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Our products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Our active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP. Read MoreK FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Posted on Dec 24th
TTK Healthcare submits postal ballot notice
Posted on Dec 24th
Rahul Gandhi accuses BJP of empowering monopolies, burdening small traders
Posted on Dec 24th
E to E Transportation Infrastructure coming with IPO to raise Rs 84 crore
Posted on Dec 24th
Currency futures for December expiry trade weaker with 0.98% increase in OI
The issue size of Anlon Healthcare Ltd. IPO is ₹114.38 - 121.03 crore.
The Anlon Healthcare Ltd. IPO opens for subscription on 2025-08-26 and closes on 2025-08-29.
The price range of Anlon Healthcare Ltd. IPO is ₹86.00 to ₹91.00.
The lot size of Anlon Healthcare Ltd. IPO is 164 shares.
The registrar of Anlon Healthcare Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.